Related by context. All words. (Click for frequent words.) 67 bone metabolism 65 lipoprotein metabolism 64 carbohydrate metabolism 64 PPARγ 63 endothelial activation 62 elevated triglyceride levels 62 estrogen metabolism 62 myopathies 62 Genetic variation 61 gene polymorphisms 61 redox active 61 metabolized differently 61 resistin 61 aminotransferase 61 PI3K signaling 61 hyperinsulinemia 61 MTHFR 61 cardiometabolic disorders 61 metabolizing enzyme 61 type2 diabetes 61 genetic polymorphism 60 eicosanoids 60 Calcium intake 60 COX enzymes 60 colorectal carcinogenesis 60 atherogenesis 60 metabolizing enzymes 60 adipokines 60 CYP #A# 60 ABCB1 60 CB2 receptor 60 stimulated insulin secretion 60 WNK1 60 triglyceride metabolism 60 motor neuron degeneration 60 improves insulin sensitivity 60 #beta HSD1 60 Peptide YY 60 missense mutations 60 gene polymorphism 60 neuroactive 59 hormone adiponectin 59 toxic amyloid beta 59 oxysterols 59 impaired glucose metabolism 59 Thyroid hormone 59 arachidonic acid AA 59 metabolic disturbances 59 glycated 59 Glutamic acid 59 adipocyte 59 bile acid synthesis 59 glucose homeostasis 59 prodynorphin 59 Glucocorticoids 59 folate metabolism 59 mitochondrial metabolism 59 thyrotropin 59 Genetic variations 59 Skeletal muscle 59 apolipoproteins 59 γ secretase 59 metabolic dysfunction 59 Elevated serum 59 improves glycemic 59 prostate carcinogenesis 59 microangiopathy 59 hypothalamic pituitary 59 nephrolithiasis 59 hydroxylase 59 HMGCR 59 UCP1 59 platelet activation 59 FGFs 58 protein alpha synuclein 58 cardioprotective effects 58 p# activation 58 hormone secretion 58 renal tubular 58 steroidogenic 58 glucocorticoid induced 58 glucose triglycerides 58 Oxidative damage 58 urothelial cancer 58 visceral abdominal 58 Lp PLA 2 58 ADAMTS# 58 adrenal hormone 58 multifactorial disease 58 neurons degenerate 58 diabetic kidney 58 gastric carcinoma 58 metabolic abnormalities 58 biochemical abnormalities 58 myocardial dysfunction 58 proinflammatory mediators 58 alpha synuclein protein 58 growth hormone secretion 58 erythropoietic 58 thromboembolic disease 58 abnormal lipids 58 gut microbiota 58 leptin deficiency 58 prognostic biomarker 58 VLDL cholesterol 58 bile acid 58 plasma lipids 58 oxidases 58 PON1 58 hyperinsulinism 58 Cystatin C 58 nonalcoholic steatohepatitis NASH 58 amyloid β 58 abnormal glucose metabolism 58 sphingolipids 58 Parathyroid hormone 58 ERK signaling 58 dyslipidemias 58 immunopathology 58 arterial calcification 58 neovascularisation 58 diabetes dyslipidemia 58 diagnostic biomarker 57 causal pathway 57 HLA DRB1 57 activated microglia 57 untreated celiac disease 57 haematologic 57 calcium oxalate stones 57 induced hepatotoxicity 57 xenobiotic 57 muscarinic receptors 57 airway remodeling 57 synovial cells 57 Genetic predisposition 57 neuropathologic 57 apoC III 57 Genetic variants 57 monogenic 57 flavonoid compounds 57 glycogen metabolism 57 amyloidogenic 57 neuronal differentiation 57 intrahepatic 57 Heritability 57 pleiotropic effects 57 Wernicke Korsakoff syndrome 57 obesity insulin resistance 57 ß amyloid 57 macrovascular complications 57 polyarticular 57 induce insulin resistance 57 testicular germ cell 57 oncogenesis 57 HIF 1α 57 ovarian hormones 57 prostaglandin synthesis 57 vasodilatation 57 macrophage infiltration 57 endogenous opioid 57 receptor subtypes 57 inflammatory biomarkers 57 calcium homeostasis 57 etiologic factors 57 lipodystrophy syndrome 57 mitochondrial oxidative 57 LDL receptor 57 excess uric acid 57 liver steatosis 57 nephron 57 lipid abnormalities 57 antiphospholipid syndrome 57 inversely associated 57 lung epithelium 57 hereditary predisposition 57 endogenous hormones 57 leptin receptor 57 fat soluble vitamin 56 macrovascular events 56 renal excretion 56 HPA axis 56 myeloproliferative diseases 56 predisposing factor 56 overactivated 56 catabolism 56 JAK2 enzyme 56 HIV HCV coinfected 56 lymphocyte activation 56 neuroregenerative 56 elevated homocysteine 56 synaptic function 56 neuro developmental disorders 56 cholesterol metabolism 56 mGluR2 NAM 56 plasma lipid 56 stratifying patients 56 pathophysiological mechanisms 56 podocyte 56 CHD5 56 Chronic myeloid leukemia 56 inherited mutations 56 mitochondrial biogenesis 56 renal osteodystrophy 56 genetic polymorphisms 56 Singh Manoux 56 amyloid peptide 56 circadian genes 56 lipid metabolism 56 urinary excretion 56 glucokinase 56 neuronal dysfunction 56 immune modulating 56 ductal adenocarcinoma 56 physiologic functions 56 basal cell nevus syndrome 56 β carotene 56 erythropoiesis 56 glucose reabsorption 56 CDK5 56 pituitary hormone 56 etiologic 56 tau protein tangles 56 thyroid deficiency 56 apoE 56 neurocognitive deficits 56 triacylglycerol 56 LRP5 56 Angiotensin converting enzyme 56 proteoglycan 56 dietary antioxidants 56 fibrotic disease 56 SSc 56 folic acid vitamin B# 56 impaired insulin secretion 56 TXNIP 56 acetylcholine receptor 56 hyperglycaemia 56 TMPRSS6 56 serum lipid levels 56 MYCN amplification 56 genetic loci 56 cardio metabolic 56 pyridoxine 56 vitamin D calcium 56 murine models 56 phenotypic expression 56 beta amyloid peptide 56 dopamine receptor gene 56 neuronal signaling 56 G6PD deficiency 56 neuritic 56 epigenetic alterations 56 potentially modifiable 56 NFTs 56 SIRT1 gene 56 dysregulation 56 ergot alkaloids 56 Fas ligand 56 HeFH 56 glycolipid 56 antidepressants SSRIs 56 losing enteropathy 56 transgenic mouse models 55 cytochromes P# 55 Clusterin 55 pathological hallmark 55 mitochondrial toxicity 55 hypothalamic pituitary adrenal axis 55 physico chemical properties 55 glucagon secretion 55 sirtuin activators 55 bile acid metabolism 55 osteocalcin protein 55 biologic plausibility 55 HER2 expression 55 biologic pathways 55 physiologic mechanisms 55 adiponectin levels 55 adrenocortical 55 ALI ARDS 55 proximal tubule 55 liver enlargement hepatomegaly 55 T1DM 55 underlying pathophysiology 55 neuroinflammatory 55 endocannabinoid signaling 55 abnormal lipid levels 55 insulin resistance syndrome 55 transcriptional regulation 55 BDNF protein 55 GH deficiency 55 beta globin gene 55 endocrinologic 55 sonographic diagnosis 55 potent inhibitors 55 prothrombotic 55 periodontal tissues 55 Wnt signaling pathway 55 insulin sensitizing drugs 55 GBA mutations 55 Mechanistic studies 55 intestinal microbiota 55 postmenopausal estrogen 55 transcriptional activity 55 antioxidant supplementation 55 anatomical abnormalities 55 baroreceptor 55 nondemented 55 phosphorylated tau 55 Treg cell 55 hormone receptor status 55 bronchoalveolar 55 ABCA1 55 Aβ# 55 endothelial dysfunction 55 neurosteroid 55 mitochondrial enzyme 55 lipofuscin 55 hematopoetic 55 autosomal dominant inheritance 55 lipid homeostasis 55 myocyte 55 visceral adiposity 55 Dietary fat 55 alpha#beta# 55 gene locus 55 glycosaminoglycans 55 neuronal plasticity 55 abnormal proteins 55 lymphatic vasculature 55 inborn errors 55 nonhereditary 55 bile salts 55 SORL1 gene 55 prognostic indicator 55 Estrogen Receptor 55 hepatic cirrhosis 55 improving insulin sensitivity 55 #q# deletion 55 peptide YY 55 anti androgens 55 functional polymorphism 55 lipid peroxides 55 K ras mutations 55 familial clustering 55 clefting 55 developmental neurotoxicity 55 flavonoid intake 55 amyloid beta plaques 55 dysglycemia 55 β amyloid 55 CREB protein 55 metabolic abnormality 55 Prognostic factors 55 rheumatic disorders 55 leukemia inhibitory 55 atopic disease 55 systemic inflammation 55 palmitic acid 55 arterial plaques 54 Caspases 54 glomerular 54 Aâ 54 airway hyperresponsiveness 54 Chronic inflammation 54 serum PTH 54 causal pathways 54 lipid elevations 54 PTH secretion 54 unmeasured factors 54 esophageal squamous cell carcinoma 54 Polyunsaturated fatty acids 54 immune dysregulation 54 MTHFD1L gene 54 cAMP signaling 54 elevated ALT 54 tumor histology 54 metabolic dysfunctions 54 p# mutations 54 induced oxidative stress 54 intact parathyroid hormone 54 synaptogenesis 54 protein excretion 54 FGFR2 54 Unsaturated fats 54 perfusion abnormalities 54 etiologic agent 54 eicosapentaenoic acid 54 malabsorptive 54 dietary acrylamide 54 cholesterol homeostasis 54 PI3K Akt 54 fasting triglycerides 54 dysregulated 54 microvascular dysfunction 54 amyloid â 54 ketogenic diets 54 molecular abnormalities 54 chromosomal rearrangement 54 C. pneumoniae 54 micro RNAs 54 MAP kinases 54 circulating endothelial cells 54 PDE7B 54 c myc gene 54 Amyloid Precursor Protein 54 circulating estrogens 54 receptor tyrosine kinases RTKs 54 SLC#A# [002] 54 neuroligins 54 INTERHEART study 54 neurotrophic 54 breast cancer metastasis 54 neuropathological 54 hormones leptin 54 SNCA 54 T2DM 54 anthropometric measures 54 anterior pituitary 54 pathophysiologic mechanism 54 Cognitive impairment 54 polyunsaturated fatty acid 54 clinicopathological 54 Rab# 54 beta1 integrin 54 carotid plaques 54 exocrine glands 54 immunodeficient 54 TRAIL induced apoptosis 54 circulating IGF 54 constitutively expressed 54 opioid peptides 54 C1q 54 nodal metastasis 54 morphological abnormalities 54 metabolic parameters 54 hepatic enzyme 54 shortened telomeres 54 MGUS 54 atypical neuroleptics 54 cataract formation 54 hormone aldosterone 54 neurocognitive impairment 54 HDL particle 54 Insulin resistance 54 serum IGF 54 autophagic 54 thyrotropin levels 54 mitochondrial abnormalities 54 obstructive lung 54 obesity sedentary lifestyle 54 lipid peroxidation 54 podocytes 54 diabetes mellitus DM 54 neurodevelopmental outcome 54 adrenal function 54 familial hypercholesterolemia 54 serum leptin 54 CVD cardiovascular disease 54 susceptibility locus 54 chemoresistant 54 folate concentrations 54 diabetic microvascular complications 54 metabolic derangements 54 biochemical imbalances 54 myelofibrosis polycythemia vera 54 glial tumors 54 abnormal lipid 54 antibody mediated 54 STAT3 signaling 54 prostate cancer CaP 54 genetic variants associated 54 oral prednisolone 54 Aß 54 FOXO3a 54 PTPN# 54 metabolic syndromes 54 Vitamins minerals 54 fibrin deposition 54 vitamin D receptors 54 prognostic marker 54 LKB1 54 GCN2 54 Iron deficiency anemia 54 epithelial tumors 54 de novo mutations 54 ceruloplasmin 54 coronary artery aneurysms 54 lipid biosynthesis 54 anticarcinogenic 54 neuritic plaques 54 MAPK pathway 54 primary aldosteronism 54 chromosomal anomalies 53 diabetic polyneuropathy 53 cathepsins 53 underactive thyroids 53 Smad3 53 Reactive oxygen species 53 metabolomic profiles 53 SMAD4 53 hydrolysed 53 hepatic steatosis 53 pancreas secretes insulin 53 prostate cancer PCa 53 meta analytic 53 alpha syn 53 shorter telomere length 53 TMPRSS2 ERG fusion 53 LRRK2 mutations 53 essential thrombocythemia 53 left ventricular diastolic 53 GSTM1 gene 53 Dysregulation 53 molecular determinants 53 AMP kinase 53 fat malabsorption 53 plasma pharmacokinetics 53 neuroinflammation 53 oxidative stresses 53 hypothalamic amenorrhea 53 regulates gene expression 53 fatty acid synthase 53 KRAS mutational status 53 arterial stiffening 53 gene rearrangements 53 activate AMPK 53 thrombopoietin TPO natural 53 mitochondrial mutations 53 subclinical atherosclerosis 53 cardiac hypertrophy 53 overactivation 53 sporadic ALS 53 autocrine 53 surrogate markers 53 ß carotene 53 CYP#D# 53 hyperphosphorylation 53 microdeletion 53 MYH9 53 neuropsychiatric disorders 53 androgen receptor gene 53 APOE genotype 53 metabolic alterations 53 IgA deficiency 53 dysbindin 53 fats lipids 53 radiographic findings 53 CYP#D# genotype 53 mitochondrial oxidative phosphorylation 53 cardioprotective effect 53 immunotoxicity 53 insulinlike growth 53 KATP channel 53 PARP inhibition 53 mechanistic studies 53 Magnesium deficiency 53 cortisol secretion 53 Vitamin B# deficiency 53 mal absorption 53 nonhuman primate model 53 dietary intakes 53 GABA receptor 53 polycythemia vera PV 53 membrane phospholipids 53 maternally derived 53 comorbid disorders 53 serum lipids 53 germline mutations 53 RCAN1 53 Broccoli sprouts 53 chronic hepatitis cirrhosis 53 muscular dystrophies 53 arachidonic 53 Oxidative stress 53 serum markers 53 lipid parameters 53 glucocorticoid hormones 53 anabolic hormone 53 buffalo hump 53 neurological abnormalities 53 liver metastasis 53 hepatic lipase 53 IgE antibody 53 anabolism 53 colonic mucosa 53 hypercalciuria 53 chemosensitivity 53 visceral fat accumulation 53 prenatal exposures 53 lipid accumulation 53 brain neurotransmitter 53 varicella infection 53 chorioamnionitis 53 pharmacodynamic parameters 53 CaM kinase II 53 Colon polyps 53 TCF#L# gene 53 bronchial epithelial cells 53 Abeta# 53 telomere lengths 53 rheumatoid arthritis lupus 53 thyroid dysfunction 53 genetic determinants 53 6 phosphate dehydrogenase 53 Isoflavones 53 dietary carbohydrate 53 TNF blocker therapy 53 hypothalamic pituitary adrenal HPA 53 striatal dopamine 53 mucopolysaccharides 53 Sjögren syndrome 53 Fibroblast growth 53 Vitamin B9 53 prescribed antipsychotics 53 triacylglycerols 53 Observational studies 53 NR#A# 53 selenium zinc 53 nerve degeneration 53 thrombo embolic 53 leptin signaling 53 mesenchymal stromal cells 53 autoantigens 53 misregulation 53 folic acid deficiency 53 hepatic insulin resistance 53 histologic subtype 53 epigenetic regulation 53 Uric acid 52 amyloid β peptide 52 circadian clock genes 52 heme oxygenase 52 adrenal cortex 52 monoclonal gammopathy 52 artery stenosis 52 drug metabolizing enzymes 52 histone methylation 52 diabetic hypertensive 52 urate crystals 52 behavioral disinhibition 52 atheroma 52 lymphoid tumors 52 KIBRA 52 cytochrome oxidase 52 Chronic pancreatitis 52 ketogenic 52 alkaline phosphatase 52 dietary nitrate 52 fatty degeneration 52 excitotoxic 52 Tasigna prolongs 52 KRAS status 52 synaptic dysfunction 52 endocrine glands 52 Dietary fats 52 obese asthmatics 52 incidentalomas 52 Chlamydia trachomatis infection 52 activated macrophages 52 amyloid deposition 52 dopamine D2 52 tumor hypoxia 52 macrovascular disease 52 enzyme renin 52 epidemiologic studies 52 idiopathic pulmonary 52 serum triglyceride levels 52 immunomodulatory effects 52 hepatic encephalopathy HE 52 pharmacologic intervention 52 Myelodysplastic syndromes MDS 52 PTEN gene 52 tau proteins 52 neuro degenerative disorders 52 Factor XIII 52 intracellular signal transduction 52 epithelial tissues 52 amyloid plaque formation 52 Adiposity 52 hypercoagulable 52 protein secreted 52 neurotransmitters serotonin 52 amyloid beta peptides 52 prognostic variables 52 dietary fatty acids 52 insulin resistance 52 LIS1 52 extramedullary 52 histone deacetylases 52 LXRs 52 pathogenic mechanisms 52 IPAH 52 vascular dysfunction 52 pathophysiologic 52 intracerebral haemorrhage 52 regulating gene expression 52 N myc 52 etiological 52 hepatocellular carcinomas 52 GPC5 52 neurexins 52 autonomic dysfunction 52 chylomicron 52 intravascular volume 52 cardioembolic stroke 52 confounder 52 Brodmann Area 52 genomic biomarker 52 Thyroid hormones 52 mechanistic insights 52 fructose intolerant 52 differentially expressed genes 52 PROactive study 52 mtDNA mutations 52 ANCA associated 52 aggregated Abeta 52 bicuspid aortic valves 52 comorbid depression 52 neuronal degeneration 52 inactivating mutations 52 cholesterol esters 52 multicenter trials 52 folate folic acid 52 comorbid psychiatric disorders 52 monounsaturated fatty acid 52 atherosclerosis regression 52 neuronal synapses 52 metabolically inert 52 lymphatic cancers 52 inherited predisposition 52 tissue homeostasis 52 melanocortin receptor 52 Methionine 52 antitumor efficacy 52 Hfq 52 GSNO 52 pathophysiological processes 52 primary biliary cirrhosis 52 Subgroup analyzes 52 HDL LDL ratio 52 retinoblastoma Rb 52 metabolizing glucose 52 Squalamine 52 Apolipoprotein E 52 intercellular signaling 52 triglyceride TG 52 survival motor neuron 52 pressure natriuresis 52 serum aminotransferase levels 52 NFKBIA 52 equimolar 52 androgen deficiency 52 biologic pathway 52 cholesteryl ester 52 aetiological 52 ultrastructural 52 generalisable 52 neuromuscular junction 52 urolithiasis 52 Amyloid beta 52 methylmalonic acid 52 FMRP protein 52 SOD2 52 mucosal inflammation 52 DNA demethylation 52 nitrite nitrate 52 BEXXAR Therapeutic Regimen 52 muscarinic receptor 52 autoantigen 52 distinct subtypes 52 mitochondrial dysfunction 52 HFE gene 52 renal fibrosis 52 peroxidation 52 modifiable lifestyle 52 lactose malabsorption 52 underlying molecular mechanisms 52 inorganic phosphates 52 serine proteases 52 digestive disturbances 52 clonal expansion 52 beta amyloid plaque 52 intestinal permeability 52 sugars carbohydrates 52 VADT 52 mRNA expression 52 epigenetic markers 52 miRNA expression 52 hyperhomocysteinemia 52 symptomatic hypotension 52 mitochondrial function 52 photoprotection 52 distal nephron 52 nmol 52 PTEN mutations 52 DNA adducts 52 channelopathies 52 researchers hypothesised 52 Essential fatty acids 52 osteopontin OPN 51 calcium oxalate 51 hypersecretion 51 hydroxyvitamin D concentrations 51 multi factorial disease 51 impair cognitive 51 huntingtin protein 51 hepatic stellate cells 51 Subtypes 51 MSH2 51 neuropsychiatric diseases 51 arteriosclerotic 51 underlying vasculopathy 51 anti HBs 51 CHD7 51 Stress hormones 51 pathophysiological 51 obese postmenopausal 51 AT1R 51 virally infected 51 islet autoimmunity 51 comorbid anxiety 51 prognostic indicators 51 NSAID induced 51 lipid oxidation 51 epithelial barrier 51 borderline statistical significance 51 ADPKD 51 Leptin hormone 51 Six3 51 repletion 51 aetiology 51 insulin signaling pathways 51 DHA fatty acid 51 histologic subtypes 51 toxicologic 51 progranulin mutations 51 renal scarring 51 TGF b 51 hamartomas 51 ZNF# 51 serum calcium 51 causative genes 51 Abdominal fat 51 inhibin B 51 modifier genes 51 cerebral microbleeds 51 pharmacodynamic markers 51 glycemia 51 proteolysis 51 glutamyl 51 BPS IC 51 Hp2 2 51 Amyloid plaques 51 iron arsenide 51 non pharmacological interventions 51 erythrocytes 51 menstrual disorders 51 adult neurogenesis 51 hypometabolism 51 prefrontal cortical 51 atherosclerotic disease 51 epigenetic modification 51 signaling cascades 51 narcolepsy cataplexy 51 Treg cells 51 pharmacokinetic interaction 51 Main Outcome Measure 51 susceptibility loci 51 molecular mechanisms underlying 51 metabolite concentrations 51 enterovirus infection 51 chylomicrons 51 BCL#A 51 creatine kinase 51 secrete insulin 51 gastrointestinal dysfunction 51 serotonin transporters 51 anticholinergic effects 51 PKC delta 51 cAMP pathway 51 delayed gastric emptying 51 Endothelial dysfunction 51 proapoptotic 51 Sirt3 51 neurosensory 51 elevated LDL 51 epigenetic changes 51 endogenous ligand 51 lysosomal enzyme 51 virulence genes 51 beta glucans 51 remyelination 51 hepatic lipid 51 mGluR5 antagonist 51 β catenin 51 HGPS 51 low carbohydrate ketogenic 51 telomere shortening 51 familial pancreatic cancer 51 glycosaminoglycan GAG 51 homeostatic 51 protein beta amyloid 51 prospective multicentre 51 hydroxyvitamin D levels 51 DNA methylation patterns 51 biologically plausible 51 glucose intolerant 51 atherothrombosis 51 osmolality 51 lipid concentrations 51 essential amino acid 51 CHI#L# 51 normoxic 51 glucose abnormalities 51 nongenetic 51 PDE# inhibitors 51 carbs fats 51 hypercoagulability 51 haemolysis 51 TLR antagonists 51 pharmacological interventions 51 protein acetylation 51 secrete hormones 51 folates 51 colonic motility 51 apigenin 51 neurologic sequelae 51 hyperplastic 51 muscle dystrophies 51 atherothrombotic 51 glucocerebroside 51 gene loci 51 pathogenic mutations 51 metaanalysis 51 histone modifications 51 innate immune responses 51 dietary interventions 51 Aβ 51 iron supplementation 51 prognostic markers 51 nutrient supplementation 51 chromosome #p# [002] 51 carotid IMT 51 ABL1 51 γδ T cells 51 senescent cells 51 waist circumference WC 51 cerebrovascular diseases 51 biochemical imbalance 51 pharmacological therapy 51 hydroxy vitamin D 51 excess glutamate 51 repolarization 51 amyloid protein 51 visceral adipose tissue 51 obstructive coronary artery 51 abnormal glucose tolerance 51 gamma tocopherol 51 TrkB 51 intracellular pH 51 axonal damage 51 demyelinating 51 DUX4 51 LDL HDL 50 uric acid crystals 50 aminotransferase levels 50 somatic mutations 50 Dr. Bezprozvanny 50 glucose concentrations 50 density lipoproteins HDL 50 folate deficiency 50 #T# L1 50 hypoglycemia unawareness 50 susceptibility genes 50 serum biomarkers 50 leukocyte infiltration 50 neuroimaging studies 50 myocardial ischaemia 50 peri implant 50 lymphangiogenesis 50 tunica vaginalis 50 hyperalgesia 50 Adequate vitamin D 50 fig. S4 50 motor neuron diseases 50 microvascular disease 50 CTEPH 50 GPIHBP1 50 guanine nucleotide exchange 50 A2A adenosine receptor 50 serum retinol 50 astrocytomas 50 metalloproteinases 50 recurrent tonsillitis 50 KIAA# 50 Acute pancreatitis 50 cerebral oxygenation 50 synaptic proteins